Cytori Reports Third Quarter 2015 Business and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Roth Capital Cuts Price Target on Cytori Therapeutics (CYTX) Following 3Q15
November 9, 2015 8:40 AM ESTRoth Capital maintained a Buy rating on Cytori Therapeutics, Inc. (NASDAQ: CYTX), and cut the price target of $2.50 (from $4.00), following the company's 3Q15 earnings report. CYTX reported EPS of $0.01 compared with the consensus estimate of ($0.06).
Analyst Joseph Pantginis commented, "With four potential approval... More
Cytori Therapeutics (CYTX) Tops Q3 EPS by 2c
November 5, 2015 5:50 PM ESTCytori Therapeutics (NASDAQ: CYTX) reported Q3 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.
... More